# Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate

> **NCT04042792** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 28 (actual)

## Conditions studied

- Rheumatic Diseases

## Interventions

- **OTHER:** pharmacokinetics (PK) measurement

## Key facts

- **NCT ID:** NCT04042792
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-26
- **Primary completion:** 2021-06-28
- **Final completion:** 2021-06-28
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04042792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04042792, "Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04042792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*